MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

April 27, 2017

MSF is bringing individual investors’ voices to Pfizer’s annual general meeting today in New Jersey.

April 25, 2017

DoD’s plans to grant an exclusive license to pharmaceutical company Sanofi on a vaccine candidate funded by the US government to combat Zika means there’s no guarantee that the vaccine will be developed, affordable or made available for those who need it most

April 03, 2017

Antibiotic resistance is happening everywhere its been looked for, including in the places where Doctors Without Borders/Médecins Sans Frontières (MSF) works. Unlike in wealthier countries, the health systems in these contexts usually don't have the resources to invest in surveillance and prevention efforts.

April 03, 2017

On Sunday, April 2, Doctors Without Borders/Médecins Sans Frontières (MSF) sent a multidisciplinary team consisting of a coordinator, a doctor, a nurse, a psychologist, and a logistician to Mocoa, Colombia, to assess the medical needs of people affected by this weekend's landslides.

The teams traveled to different parts of Colombia, where for 15 years MSF has provided primary, mental and sexual and reproductive health care to victims of armed conflict and violence in isolated populations in twenty departments of the country.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 08, 2017
WASHINGTON, MARCH 8, 2017—Judit Rius Sanjuan, Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign manager and legal policy advisor, delivered the following remarks at the United States Trade Representative's 2017 Special 301 Review hearing today.
 
Good afternoon. I would like to provide testimony on behalf of MSF.
March 02, 2017

In the Petare and La Vega neighborhoods of Caracas, Venezuela, Doctors Without Borders/Médecins Sans Frontières (MSF) offers psychological assistance to victims of violence, including sexual violence. About 45% of patients are minors.

March 02, 2017

Key House subcommittee examined bill today that amends neglected disease innovation incentive program without fixing loopholes abused by pharmaceutical corporations

February 23, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) medical staff who work at projects in the field have seen first-hand the effects of unsafe abortions. 

Pages

April 27, 2017

MSF is bringing individual investors’ voices to Pfizer’s annual general meeting today in New Jersey.

April 25, 2017

DoD’s plans to grant an exclusive license to pharmaceutical company Sanofi on a vaccine candidate funded by the US government to combat Zika means there’s no guarantee that the vaccine will be developed, affordable or made available for those who need it most

April 03, 2017

Antibiotic resistance is happening everywhere its been looked for, including in the places where Doctors Without Borders/Médecins Sans Frontières (MSF) works. Unlike in wealthier countries, the health systems in these contexts usually don't have the resources to invest in surveillance and prevention efforts.

April 03, 2017

On Sunday, April 2, Doctors Without Borders/Médecins Sans Frontières (MSF) sent a multidisciplinary team consisting of a coordinator, a doctor, a nurse, a psychologist, and a logistician to Mocoa, Colombia, to assess the medical needs of people affected by this weekend's landslides.

The teams traveled to different parts of Colombia, where for 15 years MSF has provided primary, mental and sexual and reproductive health care to victims of armed conflict and violence in isolated populations in twenty departments of the country.

March 24, 2017

NEW YORK, MARCH 24, 2017—Today, World Tuberculosis Day, Doctors Without Borders/Médecins Sans Frontières’ (MSF) is urging pharmaceutical corporations, Sequella and Pfizer, to provide open access to all existing clinical data on a promising drug, sutezolid, to help accelerate the research and development of urgently needed new, lifesaving TB treatment regimes. This data, if not released, will take years and resources to replicate, further delaying new treatment options for people living with TB.

March 08, 2017
WASHINGTON, MARCH 8, 2017—Judit Rius Sanjuan, Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign manager and legal policy advisor, delivered the following remarks at the United States Trade Representative's 2017 Special 301 Review hearing today.
 
Good afternoon. I would like to provide testimony on behalf of MSF.
March 02, 2017

In the Petare and La Vega neighborhoods of Caracas, Venezuela, Doctors Without Borders/Médecins Sans Frontières (MSF) offers psychological assistance to victims of violence, including sexual violence. About 45% of patients are minors.

March 02, 2017

Key House subcommittee examined bill today that amends neglected disease innovation incentive program without fixing loopholes abused by pharmaceutical corporations

February 23, 2017

Doctors Without Borders/Médecins Sans Frontières (MSF) medical staff who work at projects in the field have seen first-hand the effects of unsafe abortions. 

Pages